52 research outputs found

    The New Zealand management reforms

    No full text
    New Zealand has emerged from a decade of radical economic, social and administrative reform to find itself on the brink of a major change in its constitution which has significant consequences for its public service

    Ramipril: clinical and economic benefits

    No full text

    Health care resource allocation: Is the threshold rule good enough?

    No full text
    We review the foundations of resource allocation rules based on cost-effectiveness information. Comprehensive approaches, where a total budget is allocated in one go, require estimation of the costs and effects of all available health care programmes, which is unlikely to be practical. A common alternative is to assess individual programmes against a cost-effectiveness threshold. This has been shown to be efficient if the threshold is well calibrated and all programmes can be wholly or partially implemented with constant returns to scale. We discuss the feasibility of these assumptions, and the effects of relaxing them, concluding that programme indivisibility is unlikely to be a serious problem at a national level, but that miscalibration of the threshold and non-constant returns to scale might be. A rule that avoids these difficulties has been proposed previously: a new programme should only be implemented if it can be funded by cancelling another less effective programme. This could never reduce efficiency, unlike the threshold rule, though we show that it might sometimes fail to recommend an efficiency-improving change. We suggest a refinement of this reallocation rule based on explicit estimation of the costs and effects of partial implementation of the programmes under review. Research is required to assess the practicality of this optio

    Non-linearity in the cost-effectiveness frontier

    No full text
    Conventional cost-effectiveness decision rules rely on the assumptions that all health care programmes are divisible and exhibit constant returns to scale for a homogeneous population; hence, the path between adjacent programmes on a cost-effectiveness frontier must be linear. In this paper we build a framework to analyse non-linear 'expansion' paths. We model the impact of two key sources of non-linearity: economies of scale or scope in the production of health care; and prioritisation of patients who are most likely to benefit from more expensive and more effective treatments. We conclude that the expansion path might be linear, convex or concave, depending on the situation. The path might also exhibit vertical discontinuity due to fixed costs or horizontal discontinuity due to indivisibility. The efficiency of resource allocation might be improved by empirical estimation of expansion paths. We discuss the advantages and disadvantages of this approach compared with a standard stratified analysi

    Decision science in cancer research: Evaluation of FDG-PET in the surgical management of NSCLC

    No full text
    • …
    corecore